RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com

Similar
Filing Names

Janssen R x26 d Ireland
Janssen R x26 d Ireland formerly Tibotec Pharmaceuticals
  

Janssen R & d Ireland patents

Recent patent applications related to Janssen R & d Ireland. Janssen R & d Ireland is listed as an Agent/Assignee. Note: Janssen R & d Ireland may have other listings under different names/spellings. We're not affiliated with Janssen R & d Ireland, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "J" | Janssen R & d Ireland-related inventors




Date Janssen R & d Ireland patents (updated weekly) - BOOKMARK this page
05/05/16Novel 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
04/28/16Darunavir formulations
12/03/15Antibacterial compounds
10/22/15Macrocyclic purines for the treatment of viral infections
09/17/15Rsv antiviral compounds
08/27/15Pyrrolo[3,2-]pyrimidine derivatives for the treatment of viral infections and other diseases
08/20/15Azaindoles as respiratory syncytial virus antiviral agents
08/06/15Macrocyclic inhibitors of hepatitis c virus
06/25/15Novel 4-substituted 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents
06/18/15Novel 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents
06/11/151,3-dihydro-2h-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
05/21/15Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
05/21/15Uracyl spirooxetane nucleosides
04/09/15Hiv inhibiting 5-amido substituted pyrimidines
03/26/15Pyrimidine derivatives for the treatment of bacterial diseases
03/19/15Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
03/12/15Azabenzimidazoles as respiratory syncytial virus antiviral agents
03/12/15Indoles as respiratory syncytial virus antiviral agents
01/01/154,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b
12/25/14Quinazolinone derivatives as hcv inhibitors
06/19/14Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
06/19/14Pseudopolymorphic forms of a hiv protease inhibitor
05/22/14Darunavir combination formulations
05/08/14Mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance
04/17/14Macrocyclic indole derivatives useful as hepatitis c virus inhibitors
04/17/14Benzimidazole-imidazole derivatives
03/13/14Quinazoline derivatives for the treatment of viral infections and further diseases
12/05/13Imidazopyridines as respiratory syncytial virus antiviral agents
10/10/13Benzimidazole respiratory syncytial virus inhibitors
10/10/13Indoles as respiratory syncytial virus antiviral agents
10/10/13Azaindoles as respiratory syncytial virus antiviral agents
05/16/13Hetero-bicyclic derivatives as hcv inhibitors
04/25/13Preparation of 13-cyclohexyl-3-methoxy-6-[methyl-(2--ethyl)-carbamoyl]-7h-indolo-[2,1-a]-[2]-benzazepine-10-carboxylic acid
02/07/13Macrocyclic integrase inhibitors
12/06/12Computation of the combined potency of drug regimens from fitted or in vitro determined dose-response curves
11/01/12Degradable removable implant for the sustained release of an active compound
10/04/12Predictive value of il28b gene polymorphism combined with pretreatment serum ip-10 quantification for response to peginterferon and ribavirin is enhanced in comparison with any of these biomarkers alone
04/24/14Macrocyclic inhibitors of hepatitis c virus







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Janssen R & d Ireland in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Janssen R & d Ireland with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';